Join
Live feed
·
INSIDERFilingvia Quantisnow
Cerevel Therapeutics Holdings Inc. logo

Chief Scientific Officer Renger John returned 6,370 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CERE· Cerevel Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERE (Cerevel Therapeutics Holdings Inc.) and more on Quantisnow.